["Material and methods", "Bacterial strains and culture conditions", "The bacterial strains and plasmids used in this study are listed in Table\u00a01. Escherichia coli strains were grown in Luria broth liquid medium at 37\u2009\u00b0C and supplemented with 50\u2009\u00b5g/mL apramycin when necessary to maintain plasmids.Table 1Bacterial strains, plasmids and cosmids used in this study.Strain or plasmidDescriptionSource or referenceBacterial strainsNonomuraea gerenzanensisWild typeATCC\u00a039727\u0394dbv6 mutantN. gerenzanensis strain in which the dbv6 gene was replaced with an apramycin cassette6\u0394dbv22 mutantN. gerenzanensis strain in which the dbv22 gene was replaced with an apramycin cassetteThis studyKocuria rhizophilaUsed for bioassay of A40926ATCC\u00a09341Escherichia coli DH10BF_ endA1 recA1 galE15 galK16 nupG rpsL \u0394lacX74 \u039480lacZ\u0394M15 araD139 \u0394(ara-leu)7697 mcrA \u0394(mrr-hsdRMS-mcrBC) \u03bb-; host for routine subcloning experimentsInvitrogenEscherichia coli ET12567/pUZ8002(dam-13::Tn9 dcm-6) pUZ8002+(\u0394oriT); used for conjugative transfer of DNA and for demethylating plasmid DNA44Escherichia coli BW25113/pIJ790\u0394 (araD-araB)567 \u0394lacZ4787 (::rrnB-4) lacIp-4000 (lacIq) \u03bb-\nrpoS369 (Am) rph-1 \u0394 (rhaD-rhaB) 568 hsdR514: used to generate recombinant cosmid 1B145Plasmid/cosmid1B1Cosmid containing part of the dbv cluster from dbv17 to dbv3741B1\u0394dbv22Derivative of 1B1 with the inactivated dbv22 geneThis studypIJ773pUC19 containing the aac(3)IV-oriT cassette; source of the aac(3) gene37", "Bacterial strains, plasmids and cosmids used in this study.", "Strain or plasmid Description Source or reference.", "Bacterial strains.", "Nonomuraea gerenzanensis Wild type ATCC\u00a039727.", "\u0394dbv6 mutant N. gerenzanensis strain in which the dbv6 gene was replaced with an apramycin cassette 6.", "\u0394dbv22 mutant N. gerenzanensis strain in which the dbv22 gene was replaced with an apramycin cassette This study.", "Kocuria rhizophila Used for bioassay of A40926 ATCC\u00a09341.", "Escherichia coli DH10B F_ endA1 recA1 galE15 galK16 nupG rpsL \u0394lacX74 \u039480lacZ\u0394M15 araD139 \u0394(ara-leu)7697 mcrA \u0394(mrr-hsdRMS-mcrBC) \u03bb-; host for routine subcloning experiments Invitrogen.", "Escherichia coli ET12567/pUZ8002 (dam-13::Tn9 dcm-6) pUZ8002+(\u0394oriT); used for conjugative transfer of DNA and for demethylating plasmid DNA 44.", "Escherichia coli BW25113/pIJ790 \u0394 (araD-araB)567 \u0394lacZ4787 (::rrnB-4) lacIp-4000 (lacIq) \u03bb-\nrpoS369 (Am) rph-1 \u0394 (rhaD-rhaB) 568 hsdR514: used to generate recombinant cosmid 1B1 45.", "Plasmid/cosmid.", "1B1 Cosmid containing part of the dbv cluster from dbv17 to dbv37 4.", "1B1\u0394dbv22 Derivative of 1B1 with the inactivated dbv22 gene This study.", "pIJ773 pUC19 containing the aac(3)IV-oriT cassette; source of the aac(3) gene 37.", "Cell stocks of the N. gerenzanensis strains were prepared from cultures in RARE3 medium as already described34 and stored at \u221280\u2009\u00b0C. Liquid cultures were prepared by inoculating 0.2\u2009mL of the frozen stock into 20\u2009mL of RARE3 medium; after 120\u2009h of growth, 1\u2009mL of this culture was inoculated into 50\u2009mL of fresh RARE3 medium in an orbital shaker (500 \u00d7 g) in 250-mL baffled flasks at 30\u2009\u00b0C. To detect glycopeptide production, samples of culture broths at different time points were withdrawn and stored at \u221280\u2009\u00b0C before analysis. Cultivation in glycopeptide production medium was performed as already described2. Biomass was determined by measuring the cell dry weight of mycelial pellet recovered from a 1-mL culture sample after drying the pellet at 65\u2009\u00b0C for about 24\u2009h. Alternatively, the relative packed mycelial volume (%PMV) was determined after centrifugation of a 6-mL culture sample for 10\u2009min at 4000 \u00d7 g.", "For assessing induction by glycopeptides, the parental strain or the \u0394dbv4 mutant were cultivated in V40S medium as above and then transferred into (fresh) V40P medium2. After 24\u2009h at 30\u2009\u00b0C, the culture was equally divided into three flasks, and either 0.5\u2009\u00b5g/mL A40926 or 0.5\u2009\u00b5g/mL acA40926 were added, with the third flask used as no-addition control. After further 2 and 5\u2009h, 1-mL samples were collected and centrifuged to recover cells. RNA was extracted and processed as below.", "Analysis of antibiotic production", "Antibiotic production of the mutant strains was firstly evaluated using the paper disc diffusion method and Kocuria rhizophila as the assay organism as described previously35. For high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analyses, 500\u2009\u00b5L aliquots of broth cultures were collected at the time points indicated and treated as reported previously6,36.", "Construction of the \u0394dbv22 strain", "PCR targeting37 was applied to replace dbv22 with a cassette containing an apramycin-selectable marker using pIJ773 as template and the PCR primers reported in Table\u00a02. E. coli BW25113/pIJ790 bearing cosmid 1B14 was electrotransformed with the deletion cassette. Intergeneric conjugation was carried out as previously reported6. Exconjugants were analyzed by PCR (Supplementary Fig.\u00a0S5) using primers reported in Table\u00a02. One out of eleven clones analyzed contained the interrupted dbv22 gene and used for further studies. Sequencing of the PCR product confirmed that the apramycin-resistant cassette was correctly inserted in the target gene through homologous double-cross recombination.Table 2Primers used in this study.Gene(s)Forward (5\u2032-3\u2032)Reverse (5\u2032-3\u2032)Predicted size (bp)Used in RT-PCR or qRT-PCRhrdbctgatcaacaaggtcgcccggccgtacctctgcacctcg12916Sagcttgttggtggggtagtgtcaccgctacaccaggaatt470dbv3gaagaggttgcccaggtcacccgaggcgctctacatcac101dbv4cagtaattccggcttggtccaaacaggtcggcatctccc114dbv5gtggacctggcattgatcgctggtcacatcggtgtacgc101dbv6agctgtgcgctgagatcgacggcttcggcagatagtc126dbv7ccagctcgtcggtctcaccccttgacgtggttggac141dbv23gaccgcccacttgttgatcggcagctcaccacctacg110dbv24tcggaggtttgctgaaggagatcgaatccaatgcgg147Used to prepare probes for EMSAupstream 3gaatcgagcaacctcgtcaggcaggaatgggaaaggatct300upstream 4gcatcggtcttatccgaaaccgtcgcatcctcttttcttc226upstream 6tggtcgaggtctccgtgccattcgtgtcgccgtctc150upstream 7tgaaggcgacgatcaacctcctcatccctctcctccag188upstream 23gtccaggtgaacgcttggtccttcagcaaacctccgaac178upstream 24gcaggtcggaagggacatcgtgaccaagcgttcacctgg176", "Primers used in this study.", "Gene(s) Forward (5\u2032-3\u2032) Reverse (5\u2032-3\u2032) Predicted size (bp).", "Used in RT-PCR or qRT-PCR.", "hrdb ctgatcaacaaggtcgcccg gccgtacctctgcacctcg 129.", "16S agcttgttggtggggtagtg tcaccgctacaccaggaatt 470.", "dbv3 gaagaggttgcccaggtcac ccgaggcgctctacatcac 101.", "dbv4 cagtaattccggcttggtcc aaacaggtcggcatctccc 114.", "dbv5 gtggacctggcattgatcg ctggtcacatcggtgtacgc 101.", "dbv6 agctgtgcgctgagatcg acggcttcggcagatagtc 126.", "dbv7 ccagctcgtcggtctcac cccttgacgtggttggac 141.", "dbv23 gaccgcccacttgttgatc ggcagctcaccacctacg 110.", "dbv24 tcggaggtttgctgaagg agatcgaatccaatgcgg 147.", "Used to prepare probes for EMSA.", "upstream 3 gaatcgagcaacctcgtcag gcaggaatgggaaaggatct 300.", "upstream 4 gcatcggtcttatccgaaac cgtcgcatcctcttttcttc 226.", "upstream 6 tggtcgaggtctccgtgc cattcgtgtcgccgtctc 150.", "upstream 7 tgaaggcgacgatcaacc tcctcatccctctcctccag 188.", "upstream 23 gtccaggtgaacgcttggt ccttcagcaaacctccgaac 178.", "upstream 24 gcaggtcggaagggacatc gtgaccaagcgttcacctgg 176.", "Resistance assay", "The ability to form colonies of the N. gerenzanensis wild type, \u0394dbv6 and \u0394dbv22 strains was assessed by plating serial dilutions of stock cultures (prepared from frozen mycelium) on 0.25X BTT plates38 containing 0, 0.1, 0.2, 0.5, 1.0, 2.0 or 4.0\u2009\u00b5g/mL A40926 or acA40926. Two replicate plates were used for each antibiotic concentration. After 6 days at 30\u2009\u00b0C, the number of colony forming units (CFU) was recorded.", "Total RNA isolation and qRT-PCR analysis", "To perform transcriptional analysis, a 6-mL sample was withdrawn from a 30-mL culture. The mycelium was harvested by centrifugation and RNA was extracted using the RNeasy midi kit (Qiagen), followed by treatment with DNase I (Roche) according to the manufacturer\u2019s instructions. RNA quality was previously checked using Reverse transcription (RT)-PCR analysis as previously described39. It was converted to cDNA as already described34 and amplified using primers reported in Table\u00a02. As control genes, hrdB, encoding a vegetative sigma factor, or 16S rRNA, were used. Gene expression was analyzed quantitatively by using the 7300 real-time PCR system (Applied Biosystems) with SYBR green PCR master mix (Applied Biosystems) in 96-well plates. Two microliters of cDNA was added to 20\u2009\u00b5L of the PCR mixture. Amplification required activation of AmpErase UNG at 50\u2009\u00b0C for 2\u2009min, followed by denaturation at 95\u2009\u00b0C for 10\u2009min and then 40 cycles at 95\u2009\u00b0C for 15\u2009s and 60\u2009\u00b0C for 1\u2009min.", "Overexpression and purification of recombinant protein His-Dbv6", "Escherichia coli DH10B and BL21 (Invitrogen) were used in this study. Plasmids pGEM-T (Promega) and pRSETB (Invitrogen) were used for cloning PCR products, and protein expression, respectively. N. gerenzanensis chromosomal DNA was used as template to amplify dbv6 by PCR using the primers 5\u2019-aaaaggatccaatgcgcgttctggtggtgga-3\u2019 and 5\u2019-ttttaagctttcagatgcgatatccctcgc-3\u2019 (underlines indicate the BamHI and HindIII sites, respectively). The amplified fragment was digested with BamHI plus HindIII and ligated into the BamHI and HindIII sites of pRSETB, yielding pRSET-Dbv6, which was introduced into BL21(DE3)pLysS cells by heat shock treatment40. Plasmid pRSET-Dbv6 expresses the entire Dbv6 protein with a His6 tag at its N terminus under the control of the T7 promoter and the lac operator. Fidelity of PCR amplification was confirmed by DNA sequencing. Dbv6 overexpression and purification were performed using the procedures already described for Dbv45.", "Gel mobility shift assay", "The gel mobility shift assay was performed according to the method already described41. Briefly, for the binding assay, increasing amount of Dbv6 (2.8 to 14\u2009\u00b5g) was incubated for 10\u2009min at 4\u2009\u00b0C in 20\u2009\u03bcL of 12.5\u2009mM Tris-HCl (pH 7.5), 10% glycerol, 62.5\u2009mM KCl, 0.75\u2009mM DTT, and 5\u2009mM MgCl2. After 15\u2009min of incubation with 100\u2009ng of DNA, complexes and free DNA were resolved on non-denaturing 5% polyacrylamide gels run in 0.5\u00d7 Tris-borate-EDTA buffer at 150\u2009V for approximately 2\u2009h and then stained in a bath containing ethidium bromide. The DNA probes were amplified by PCR using the primers listed in Table\u00a02. BSA and the internal region of hrdB were used in control experiment (Supplementary Fig.\u00a04).", "Phylogenetic analysis", "Thirteen response regulators and ten sensory kinases were retrieved from the MiBIG database of characterized actinobacterial biosynthetic gene clusters23; and forty-one response regulators and forty-seven sensory kinases were identified by blast searches of the N. gerenzanensis genome18. Seven characterized TCSs from S. coelicolor (AbsA, Afs, Dra, Glu, Osd, Pho and Van)24,25 were also included. Sequences associated with N. gerenzanensis biosynthetic gene clusters were identified by AntiSMASH 5.042. Sequence alignments and phylogenetic analyses were performed with the MEGA 7 package43."]